These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 519209)
21. Association of N-acetyltransferase 1 polymorphism and bladder cancer risk: an updated meta-analysis and trial sequential analysis. Xu Z; Li X; Qin Z; Xue J; Wang J; Liu Z; Cai H; Yu B; Xu T; Zou Q Int J Biol Markers; 2017 Jul; 32(3):e297-e304. PubMed ID: 28604993 [TBL] [Abstract][Full Text] [Related]
22. SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk. Bui HT; Fujimoto N; Kubo T; Inatomi H; Matsumoto T Cancer Invest; 2014 Jul; 32(6):256-61. PubMed ID: 24762081 [TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer. Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975 [TBL] [Abstract][Full Text] [Related]
24. Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population. Hosen MB; Salam MA; Islam MF; Hossain A; Hawlader MZ; Kabir Y Tumour Biol; 2015 Aug; 36(8):6369-74. PubMed ID: 25801242 [TBL] [Abstract][Full Text] [Related]
25. No association between SOD2 or NQO1 genotypes and risk of bladder cancer. Terry PD; Umbach DM; Taylor JA Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):753-4. PubMed ID: 15767364 [No Abstract] [Full Text] [Related]
26. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859 [TBL] [Abstract][Full Text] [Related]
27. Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review. Wieczorek E; Wasowicz W; Gromadzinska J; Reszka E Int J Urol; 2014 Aug; 21(8):744-52. PubMed ID: 24635493 [TBL] [Abstract][Full Text] [Related]
28. Genetic and epigenetic aspects of bladder cancer. Kim WJ; Quan C J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278 [TBL] [Abstract][Full Text] [Related]
29. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk. Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842 [TBL] [Abstract][Full Text] [Related]
32. Genome-wide association studies in bladder cancer: first results and potential relevance. Kiemeney LA; Grotenhuis AJ; Vermeulen SH; Wu X Curr Opin Urol; 2009 Sep; 19(5):540-6. PubMed ID: 19553824 [TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of epidemiological studies of association of P53 codon 72 polymorphism with bladder cancer. Li DB; Wei X; Jiang LH; Wang Y; Xu F Genet Mol Res; 2010 Aug; 9(3):1599-605. PubMed ID: 20730711 [TBL] [Abstract][Full Text] [Related]
34. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K Arch Toxicol; 2012 Sep; 86(9):1369-78. PubMed ID: 22532026 [TBL] [Abstract][Full Text] [Related]
35. Genetic variation in the base excision repair pathway and bladder cancer risk. Figueroa JD; Malats N; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N; García-Closas M Hum Genet; 2007 Apr; 121(2):233-42. PubMed ID: 17203305 [TBL] [Abstract][Full Text] [Related]
36. CYP1B1 gene polymorphisms correlate with an increased risk of urinary bladder cancer in India. Sankhwar M; Sankhwar SN; Abhishek A; Gupta N; Rajender S Urol Oncol; 2016 Apr; 34(4):167.e1-8. PubMed ID: 26707614 [TBL] [Abstract][Full Text] [Related]
37. Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis. Traczyk-Borszynska M; Borkowska E; Jablonowski Z; Jedrzejczyk A; Pietrusinski M; Kaluzewski B; Sosnowski M; Borowiec M Neoplasma; 2016; 63(6):952-960. PubMed ID: 27596295 [TBL] [Abstract][Full Text] [Related]
38. MTHFR gene polymorphisms in bladder cancer in the Turkish population. Izmirli M; Inandiklioglu N; Abat D; Alptekin D; Demirhan O; Tansug Z; Bayazit Y Asian Pac J Cancer Prev; 2011; 12(7):1833-5. PubMed ID: 22126575 [TBL] [Abstract][Full Text] [Related]
39. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357 [TBL] [Abstract][Full Text] [Related]
40. Accumulation of genetic changes during the development and progression of bladder cancer. Cianciulli AM; Merola R; Vico E; Orlandi G; Sentinelli S; Gallucci M Pathologica; 2005 Aug; 97(4):177-8. PubMed ID: 16440640 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]